Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Expression of TRAIL, DR4, and DR5 in bladder cancer: correlation with response to adjuvant therapy and implications of prognosis.
Li Y, Jin X, Li J, Jin X, Yu J, Sun X, Chu Y, Xu C, Li X, Wang X, Kakehi Y, Wu X.
Urology. 2012 Apr;79(4):968.e7-15. Epub 2012 Jan 11.
Related citations
Re: Cheng et al.: shRNA targeting PLC inhibits bladder cancer cell growth in vitro and in vivo (Urology 2011;78:474e.7-474e.11).
Xu Z, Wei B, Ruan J, Zhu M, Hu Q, Wang Q, Wang Z.
Urology. 2011 Dec;78(6):1446-7. No abstract available.
Milk and dairy consumption and risk of bladder cancer: a meta-analysis.
Li F, An SL, Zhou Y, Liang ZK, Jiao ZJ, Jing YM, Wan P, Shi XJ, Tan WL.
Urology. 2011 Dec;78(6):1298-305.
Up-regulation of plakophilin-2 and Down-regulation of plakophilin-3 are correlated with invasiveness in bladder cancer.
Takahashi H, Nakatsuji H, Takahashi M, Avirmed S, Fukawa T, Takemura M, Fukumori T, Kanayama H.
Urology. 2012 Jan;79(1):240.e1-8. Epub 2011 Nov 25.
Changing patterns (age, incidence, and pathologic types) of schistosoma-associated bladder cancer in Egypt in the past decade.
Salem HK, Mahfouz S.
Urology. 2012 Feb;79(2):379-83. Epub 2011 Nov 23.
Utility of urothelial mRNA markers in blood for staging and monitoring bladder cancer.
Marín-Aguilera M, Mengual L, Ribal MJ, Ars E, Ríos J, Gázquez C, Villavicencio H, Alcaraz A.
Urology. 2012 Jan;79(1):240.e9-15. Epub 2011 Nov 4.
Editorial comment.
Berglund RK.
Urology. 2011 Nov;78(5):984; author reply 984-5. No abstract available.
Oncological and functional outcomes after robot-assisted radical cystectomy: critical review of current status.
Orvieto MA, DeCastro GJ, Trinh QD, Jeldres C, Katz MH, Patel VR, Zorn KC.
Urology. 2011 Nov;78(5):977-84. Epub 2011 Sep 3. Review.
Smoking knowledge assessment and cessation trends in patients with bladder cancer presenting to a tertiary referral center.
Guzzo TJ, Hockenberry MS, Mucksavage P, Bivalacqua TJ, Schoenberg MP.
Urology. 2012 Jan;79(1):166-71. Epub 2011 Oct 26.
Use of restaging bladder tumor resection for bladder cancer among Medicare beneficiaries.
Skolarus TA, Ye Z, Montgomery JS, Weizer AZ, Hafez KS, Lee CT, Miller DC, Wood DP Jr, Montie JE, Hollenbeck BK.
Urology. 2011 Dec;78(6):1345-9. Epub 2011 Oct 11.
Patient resources available to bladder cancer patients: a pilot study of healthcare providers.
Lee CT, Mei M, Ashley J, Breslow G, O'Donnell M, Gilbert S, Lemmy S, Saxton C, Sagalowsky A, Sansgiry S, Latini DM; Bladder Cancer Think Tank; Bladder Cancer Advocacy Network.
Urology. 2012 Jan;79(1):172-7. Epub 2011 Oct 11.
Lamm DL.
Urology. 2011 Oct;78(4):854-5. No abstract available.
Detection of circulating tumor cells in metastatic and clinically localized urothelial carcinoma.
Flaig TW, Wilson S, van Bokhoven A, Varella-Garcia M, Wolfe P, Maroni P, Genova EE, Morales D, Lucia MS.
Urology. 2011 Oct;78(4):863-7. Epub 2011 Aug 2.
A 72-year-old male with left testicular pain. Diagnosis: BCG granuloma of the epididymis.
Williams SB, Viani KL, Loughlin KR.
Urology. 2011 Sep;78(3):505-7. Epub 2011 Jul 20. No abstract available.
Potential use of RNA interference as therapeutic strategy in urologic cancer.
Green WJ, James PA, Ratan HL.
Urology. 2011 Sep;78(3):500-4. Epub 2011 Jul 13. No abstract available.
Diminished efficacy of Bacille Calmette-Guérin among elderly patients with nonmuscle invasive bladder cancer.
Margel D, Alkhateeb SS, Finelli A, Fleshner N.
Urology. 2011 Oct;78(4):848-54. Epub 2011 Aug 16.
Re: Liberman et al.: Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder (Urology 2011;77:660-663).
Papadopoulos G, Doumas K.
Urology. 2011 Aug;78(2):486-7; author reply 487-8. No abstract available.
Robotic-assisted nephroureterectomy and bladder cuff excision without intraoperative repositioning.
Hemal AK, Stansel I, Babbar P, Patel M.
Urology. 2011 Aug;78(2):357-64. Epub 2011 Jun 16.
Ethnic differences in bladder cancer survival.
Yee DS, Ishill NM, Lowrance WT, Herr HW, Elkin EB.
Urology. 2011 Sep;78(3):544-9. Epub 2011 Jul 22.
Novel immunotherapy for metastatic bladder cancer using vaccine of human interleukin-2 surface-modified MB 49 cells.
Zhang X, Shi X, Li J, Hu Z, Guo F, Huang X, Zhang Z, Sun P, Jing Y, Gao J, Tan W.
Urology. 2011 Sep;78(3):722.e1-722.e6. Epub 2011 Jul 13.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on